Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2003 3
2004 3
2006 1
2007 1
2008 3
2009 7
2010 3
2011 6
2012 4
2013 2
2014 4
2015 3
2016 8
2017 7
2018 4
2019 5
2020 2
2021 6
2022 4
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA. Scott IU, et al. Among authors: vanveldhuisen pc. Ophthalmology. 2024 Apr 1:S0161-6420(24)00136-2. doi: 10.1016/j.ophtha.2024.02.016. Online ahead of print. Ophthalmology. 2024. PMID: 38573249 No abstract available.
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment.
Luo SX, Feaster DJ, Liu Y, Balise RR, Hu MC, Bouzoubaa L, Odom GJ, Brandt L, Pan Y, Hser YI, VanVeldhuisen P, Castillo F, Calderon AR, Rotrosen J, Saxon AJ, Weiss RD, Wall M, Nunes EV. Luo SX, et al. Among authors: vanveldhuisen p. JAMA Psychiatry. 2024 Jan 1;81(1):45-56. doi: 10.1001/jamapsychiatry.2023.3596. JAMA Psychiatry. 2024. PMID: 37792357
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. Among authors: vanveldhuisen pc. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. Among authors: vanveldhuisen pc. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Patient registries for substance use disorders.
Tai B, Hu L, Ghitza UE, Sparenborg S, VanVeldhuisen P, Lindblad R. Tai B, et al. Among authors: vanveldhuisen p. Subst Abuse Rehabil. 2014 Jul 24;5:81-6. doi: 10.2147/SAR.S64977. eCollection 2014. Subst Abuse Rehabil. 2014. PMID: 25114612 Free PMC article.
SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group. Scott IU, et al. Among authors: vanveldhuisen pc. Ophthalmology. 2017 Feb;124(2):245-256. doi: 10.1016/j.ophtha.2016.09.038. Epub 2016 Nov 15. Ophthalmology. 2017. PMID: 27863843 Free PMC article. Clinical Trial.
79 results